N-(2-Methyl-5,6,7,8-tetrahydro-quinazolin-6-yl)-acetamide, 95.0%, 1g

3-Bromo-2-chlorobenzonitrile, 95.0%, 25g

1-Chloro-2-(2,2,2-trifluoroethyl)benzene, 97.0%, 1g

Sodium 5-chloropyridine-2-sulfinate, 95%, 250mg

Disodium hydrogen phosphate heptahydrate, min. 98%, pa, ACS, 500 g, plastic packaging.

(2s)-2-Benzenesulfonamidopropanoic acid, 95%, 5g

(4-Chloro-benzoylamino)-acetic acid, 95.0%, 250mg

Bis((S)-4-phenyl-4,5-dihydrooxazol-2-yl)methane, 95.0%, 1g

Cyclopentanone>99.0%(GC)500mL

5-Methylamino-pentanoic acid, 1g

4'-(Trifluoromethyl)acetophenone>98.0%(GC)25g

1-[(Bromodichloromethyl)sulfonyl]-4-chlorobenzene, 250mg

(Z)-N-(1-Chloro-3-oxo-3-(piperidin-1-yl)-1-(p-tolyl)prop-1-en-2-yl)benzamide, 95.0%, 100mg